A 2 year old girl is reported in whom deployment of the Amplatzer ductal occluder caused significant aortic obstruction, requiring surgical removal of the device. This case emphasises the need for careful echocardiographic and angiographic assessment of the position of the Amplatzer ductal occluder before and after detaching the device from its delivery system, with particular emphasis on the p...

background: t ranscatheter closure of patent ductus arteriosus (pda) has become an alternative treatment to surgery. we evaluated the long-term results of the transcatheter closure of pda with the amplatzer duct occluder (ado) in children. methods: between may 2004 and october 2012, 138 children with pda (43 males and 95 females) underwent transcatheter pda closure. clinical, electrocardiograph...

(A) Before the procedure, large residual ventricular septal shunts could be seen between the occluder and the peak of apex (Online Video 1). (B) After the procedure, the shunts decreased significantly (Online Video 2). LV 1⁄4 left ventricle; RV 1⁄4 right ventricle. A 58-year-old man with exertional dyspnea (New York Heart Association class II) was admitted to our hospital. He suffered from acut...

T he first atrial septal defects (ASDs) were closed percutaneously in 1974 and reports about their closure published in 1976. In the 1980s the Rashkind occluder was introduced and revived the interest in the topic, focusing for the first time on the patent foramen ovale (PFO). This device is still available in two modified versions. Its initial name, Rashkind Clamshell occluder, has been change...

The feasibility and safety of transvenous closure of atrial septal defects by a new device was tested in 20 piglets, in which atrial septal defects were created by foramen ovale dilatation with angioplasty balloons. The device was small enough to be introduced in a 7F or 8F sheath, and it measured 20-25 mm. It has no hooks and consists of a foam occluder from the left atrium and a counter-occlu...

T he first atrial septal defects (ASDs) were closed percutaneously in 1974 and reports about their closure published in 1976. In the 1980s the Rashkind occluder was introduced and revived the interest in the topic, focusing for the first time on the patent foramen ovale (PFO). This device is still available in two modified versions. Its initial name, Rashkind Clamshell occluder, has been change...

OBJECTIVE To determine the efficacy, safety and immediate complications encountered during percutaneous device closure of patent ductus arteriosus (PDA). STUDY DESIGN Case series. PLACE AND DURATION OF STUDY Department of Paediatric Cardiology, AFIC/NIHD, Rawalpindi, from January 2005 to December 2010. METHODOLOGY Consecutive 500 patients who underwent attempted transcatheter PDA device c...

An asymptomatic 50-year-old Caucasian woman was referred to our echocardiography laboratory to monitor a Biostar septal occluder device inserted six months before in order to close a patent foramen ovale. On transthoracic echocardiography no residual shunt was observed but the device was not identifiable (Figure 1A); after injection of agitated saline solution in a vein of the right arm and the...

BACKGROUND Transcatheter closure of secundum atrial septal defects (ASD) using the Amplatzer septal occluder is generally safe and effective, but erosion into the pericardial space or aorta has been described. Although the absolute risk of this complication is low, there has been no assessment of relative risk factors. METHODS AND RESULTS All erosions reported to St. Jude Medical after ASD cl...

OBJECTIVE Percutaneous closure of perimembranous ventricular septal defects (pmVSD) has become an accepted alternative to surgical closure in selected cases. However, closure of pmVSDs associated with septal aneurysm is more challenging. We report our experience of device closure of pmVSDs associated with septal aneurysm. METHODS Between 2008 and 2012, percutaneous closure of pmVSD associated...